FDA
-
-
-
-
-
-
-
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
-
-
-
-
-
-
-
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update
-
-
-
-
-
-
-
Galectin Therapeutics to Present at the 2025 MASH-TAG Conference
-
-
-
-
-
-
-
Galectin Therapeutics to Participate in the H.C. Wainwright MASH Conference
-
-
-
-
-
-
-
Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Conference
-
-
-
-
-
-
-
Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2023, Hosted by the AASLD
-
-
-
-
-
-
-
Galectin Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference on September 13, 2023
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

